N4 Pharma Plc (LON:N4P – Get Free Report)’s share price shot up 4.5% on Monday . The company traded as high as GBX 0.70 ($0.01) and last traded at GBX 0.70 ($0.01). 5,446,512 shares traded hands during trading, an increase of 61% from the average session volume of 3,377,207 shares. The stock had previously closed at GBX 0.67 ($0.01).
N4 Pharma Stock Performance
The company has a debt-to-equity ratio of 1.62, a quick ratio of 7.28 and a current ratio of 22.73. The company has a market cap of £2.96 million, a PE ratio of -55.00 and a beta of -0.37. The company’s 50 day moving average price is GBX 0.62 and its 200-day moving average price is GBX 0.59.
About N4 Pharma
N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.
Read More
- Five stocks we like better than N4 Pharma
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Canada Bond Market Holiday: How to Invest and Trade
- What Does the Future Hold for Eli Lilly?
- Financial Services Stocks Investing
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.